TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
Redo Biosolutions AS
Closing information (x1000 DKK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
321,383
|
268,362
|
299,803 |
| Financial expenses |
2,900
|
5,422
|
3,424 |
| Earnings before taxes |
65,143
|
40,290
|
39,943 |
| Total assets |
402,941
|
377,329
|
367,881 |
| Current assets |
142,104
|
133,621
|
86,091 |
| Current liabilities |
76,304
|
75,840
|
174,161 |
| Equity capital |
301,794
|
263,662
|
140,108 |
| - share capital |
13,099
|
13,791
|
14,411 |
| Employees (average) | 16 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
74.9%
|
69.9%
|
38.1% |
| Turnover per employee | 16,773 | ||
| Profit as a percentage of turnover |
20.3%
|
15.0%
|
13.3% |
| Return on assets (ROA) |
16.9%
|
12.1%
|
11.8% |
| Current ratio |
186.2%
|
176.2%
|
49.4% |
| Return on equity (ROE) |
21.6%
|
15.3%
|
28.5% |
| Change turnover |
66,493
|
-13,019
|
96,172 |
| Change turnover % |
26%
|
-5%
|
47% |
| Chg. No. of employees | |||
| Chg. No. of employees % |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.